Stay updated with breaking news from Pharma Plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Verona Pharma plc (NASDAQ:VRNA – Get Rating) saw a large decrease in short interest in March. As of March 15th, there was short interest totalling 57,400 shares, a decrease of 33.6% from the February 28th total of 86,400 shares. Based on an average daily volume of 75,000 shares, the short-interest ratio is currently 0.8 days. […]
Investegate announcements from Redx Pharma plc, Redx to Present at the AACR Annual Meeting
Investegate announcements from N4 Pharma PLC, Result of AGM
Verona Pharma (NASDAQ:VRNA – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Tuesday, Zacks.com reports. The firm presently has a $5.75 price target on the stock. Zacks Investment Research‘s price target points to a potential upside of 18.07% from the company’s previous […]
/PRNewswire/ -- The lice treatment market size is expected to increase by USD 128.97 million from 2021 to 2026, registering a CAGR of 6.26%, according to the...